Neurocrine Biosciences | Acreedores Comerciales



Trade Creditors Cambio Fecha
AbbVie 2.94B 2.66B 2024-12
Acadia Pharmaceuticals USD 16.19M 2.89M 2024-12
Agios Pharmaceuticals USD 13.73M 2.92M 2025-03
ALKERMES USD 59.84M 14.21M 2025-03
Alnylam Pharmaceuticals USD 97.4M 8.98M 2025-03
Amgen USD 2.41B 498M 2025-03
Biogen USD 391.5M 32.7M 2025-03
BioMarin Pharmaceutical 235.4M 480.26M 2024-12
Cytokinetics USD 20.37M 8.79M 2024-12
Dynavax Technologies USD 9.06M 1.97M 2024-12
Exelixis USD 38.19M 21.12M 2025-01
Gilead Sciences USD 833M 70M 2024-12
Halozyme Therapeutics USD 10.25M 2.15M 2024-12
Incyte USD 195.54M 1.93M 2025-03
Ionis Pharmaceuticals USD 17.46M 25.51M 2025-03
Neurocrine Biosciences 110M 282.7M 2024-12
Pfizer USD 5.63B 319M 2024-12
Prothena USD 7.77M 2.56M 2024-12
Regeneron Pharmaceuticals USD 705.5M 4.18B 2025-03
Repligen USD 26.94M 5.2M 2025-03
Sarepta Therapeutics USD 214.44M 95.67M 2024-12
Teva Pharmaceutical Industries USD 2.2B 168M 2024-12
Ultragenyx Pharmaceutical USD 38.76M 2.77M 2024-12
Vertex Pharmaceuticals USD 413M 17.2M 2024-12



Neurocrine Biosciences Acreedores Comerciales - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - May 2025.